Tenet Healthcare Corporation | Separate Chair & CEO at Tenet Healthcare Corporation

Status
Omitted
Previous AGM date
Resolution details
Lead filer
Resolution ask
Adopt or amend a policy
ESG theme
  • Governance
ESG sub-theme
  • CEO / chair duality
Type of vote
Shareholder proposal
Filer type
Shareholder
Company sector
Health Care
Company HQ country
United States
Resolved clause
RESOLVED : Shareholders request that the Board of Directors adopt an enduring policy, and amend the governing documents as necessary including the Corporate Governance Guidelines in order that 2 separate people hold the office of the Chairman and the office of the CEO as soon as possible.
Supporting statement
The Chairman of the Board shall be an Independent Director. An independent Lead Director shall not be a substitute for an independent Board Chairman. The Board shall have the discretion to select an interim Chairman of the Board, who is not an Independent Director, to serve while the Board is required to seek an Independent Chairman of the Board on an accelerated basis. This policy could be phased in when there is a contract renewal for our current CEO or for the next CEO transition although it is better to adopt it now to obtain the maximum benefit. An independent Board Chairman at all times improves corporate governance by bringing impartiality, objective oversight, and external expertise to board decisions, mitigating conflicts of interest, enhancing transparency, and boosting shareholder confidence. This detached perspective allows the chairman to focus on shareholder interests , strengthen management accountability, and provide critical checks and balances. Tenet Healthcare Corporation (THC) apparently does not like shareholder input in the form of shareholder proposals. THC is believed to have used dishonest means by Mr. Chad Wiener to prevent a vote on a 2025 shareholder proposal regarding executive pay submitted to THC. An independent Board Chairman could also help THC deal with headwinds like those that emerged in 2025: In May 2025, five Tenet-owned hospitals in Florida sued The Leapfrog Group, a non-profit watchdog, to block the publication of poor THC safety grades (which included three "F" and two "D" ratings). Leapfrog then issued a cease-and-desist letter, accusing the THC hospitals of spreading false statements. A report by the state Department of Public Health (DPH) and the Centers for Medicare & Medicaid Services (CMS) found Tenet's St. Vincent Hospital in "immediate jeopardy" due to dangerous understaffing linked to at least 3 patient deaths. The hospital faced the potential termination of all Medicare and Medicaid funding, which accounts for over 70% of its revenue. THC net profit margins dropped significantly from 14% the previous year to 6%, a key warning sign for shareholders. The stock price fell by 5% after the Q3 2025 earnings report. A proposed class-action lawsuit was filed, accusing Tenet of mismanaging its employee 401(k) plan by using nearly $28 million in forfeited contributions from departing workers to reduce its own contributions, rather than using the funds to lower administrative fees. The "One Big Beautiful Bill Act" introduced policy shifts, including Medicaid cuts and tighter eligibility, which analysts estimate could cause millions of Americans to lose their healthcare coverage and create a challenging environment for the healthcare sector in late 2025 and beyond.

DISCLAIMER: By including a shareholder resolution or management proposal in this database, neither the PRI nor the sponsor of the resolution or proposal is seeking authority to act as proxy for any shareholder; shareholders should vote their proxies in accordance with their own policies and requirements.

Any voting recommendations set forth in the descriptions of the resolutions and management proposals included in this database are made by the sponsors of those resolutions and proposals, and do not represent the views of the PRI.

Information on the shareholder resolutions, management proposals and votes in this database have been obtained from sources that are believed to be reliable, but the PRI does not represent that it is accurate, complete, or up-to-date, including information relating to resolutions and management proposals, other signatories’ vote pre-declarations (including voting rationales), or the current status of a resolution or proposal. You should consult companies’ proxy statements for complete information on all matters to be voted on at a meeting.